this stock sux, page-19

I think some of the long termers, like myself (in & out in 2008 but long since 2013), are here for the um long term i.e. 2020's. I'm hoping this to be like the Regeneron story.... $14 in 1991, $3 in 1999 and then $379 in 2016.

Unilife's issue has not been market acceptance of its products.... it simply had management that DID NOT RESPECT cash management and, as others have said, the past 12 months (such as Discovery Growth Fund experience) has put the fear of god in these muppets.

I'm hoping we have either new management or a very chastened management post Amgen deal.....